| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -32.48M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ELVN returned +186.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +288.4% |
| 1 year | +186.9% |
| 5 years | +212.2% |
| All-time high | $133.96 (May 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ELVN would be worth today ›No. Enliven Therapeutics, Inc. has not paid a dividend in the past 12 months.
Enliven Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol ELVN.
Enliven Therapeutics, Inc. is part of the Healthcare sector.
Enliven Therapeutics, Inc. has a market cap of 4.38B USD, based on the latest quote.